ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NERV vs HURA // RSI-14 & 200D SMA MOMENTUM

Minerva Neurosciences Inc (NASDAQ) VS. TuHURA Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: NERV 3 — HURA 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HURA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NERV VS. HURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NERV HURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -12.63% -21.10% +8.47 NERV /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 NERV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 36.3 39.5 -3.20 HURA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $112.0M $109.6M $2.4M NERV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NERV REV HURA REV NERV GROSS % HURA GROSS % NERV FCF HURA FCF
FY 2025 $42.3M $11.5M — — -$13.5M -$27.7M
FY 2024 $61.2M $8.4M — — -$19.6M -$14.8M
FY 2023 $64.7M $67.5M — — -$14.8M -$12.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NERV // BETA —
HURA // BETA —